Atara Biotherapeutics Stock Target Price and Analyst Consensus
| ATRA Stock | USD 5.33 0.09 1.66% |
The current analyst and expert consensus on Atara Biotherapeutics is Strong Buy, with 4 strong buy opinions. The current projected Atara Biotherapeutics target price consensus is 5.00 with 5 analyst opinions. Check out Macroaxis Advice on Atara Biotherapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Atara Stock refer to our How to Trade Atara Stock guide.The most common way Atara Biotherapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Atara Biotherapeutics executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Atara Biotherapeutics. We strongly encourage you to use your own analysis of Atara Biotherapeutics to validate this buy or sell advice. Atara Biotherapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Atara Biotherapeutics target price to derive its highest and lowest estimates based on projected price volatility of 10.0783.
Lowest Forecast 4.55 | Highest Forecast 5.55 | Target Price 5 |
It's important to approach Atara Biotherapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Atara Biotherapeutics Target Price Consensus
Atara target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Atara Biotherapeutics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 5 | Strong Buy |
Most Atara analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Atara stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Atara Biotherapeutics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationAtara Biotherapeutics Target Price Projection
Atara Biotherapeutics' current and average target prices are 5.33 and 5.00, respectively. The current price of Atara Biotherapeutics is the price at which Atara Biotherapeutics is currently trading. On the other hand, Atara Biotherapeutics' target price is what analysts think the stock is worth. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Atara Biotherapeutics Market Quote on 4th of March 2026
Target Price
Analyst Consensus On Atara Biotherapeutics Target Price
Atara Biotherapeutics Analyst Ratings
Atara Biotherapeutics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Atara Biotherapeutics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Atara Biotherapeutics' financials, market performance, and future outlook by experienced professionals. Atara Biotherapeutics' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Atara Biotherapeutics price targets
Atara Biotherapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Atara Biotherapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Atara Biotherapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Atara Biotherapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Atara Biotherapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Atara Biotherapeutics is a key component of Atara Biotherapeutics valuation and have some predictive power on the future returns of a Atara Biotherapeutics.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested over 90 shares | |
 | SRI Sustainable Growth Invested over 90 shares | |
 | ESG Investing Sold few shares | |
 | Corona Opportunity Invested over 90 shares | |
Check out Macroaxis Advice on Atara Biotherapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Atara Stock refer to our How to Trade Atara Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Please note, the presentation of Atara Biotherapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Atara Biotherapeutics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Atara Biotherapeutics' management manipulating its earnings.